SDS

Page 6 of 8
SAFETY DATA SHEETQUICKSILVER HIGH PERFORMANCE GEAR
LUBE
9.17. Vapor Density (Air=1): No data available 9.18. Vapor Pressure:
0.000006 hPa estimated
9.19. VOC:
0.02 % estimated
9.20. Flammability Class:
Combustible IIIB
estimated
9.21. Viscosity @ 40°C 152cSt (152 mm²/s) 9.22. Viscosity @ 100°C 15cSt (15 mm²/s)
10. STABILITY AND REACTIVITY
10.1. Stability:
10.1.1. Stable
10.2. Incompatibility:
10.2.1. Avoid Heat, flames and sparks. Avoid temperatures exceeding the flash point
10.3. Polymerization:
10.3.1. Will not occur
10.4. Thermal Decomposition:
10.4.1. May include oxides of phosphorus. At thermal decomposition temperatures, carbon monoxide and
carbon dioxide
11. TOXICOLOGY INFORMATION
11.1. Mercury High Performance Gear Oil (Mixture)
11.1.1. Acute Dermal LD50 Rabbit: 2125.37 mg/kg estimated
11.1.2. Acute Inhalation LC50 Rat: 8298.22 mg/l estimated
11.1.3. Acute Oral LD50 Rat: 2126.08 mg/kg estimated
11.1.4. Acute Other LD50 Rat: 23170.73 mg/kg estimated
11.2. Antimony,
Tris(dipentylcarbamodithioato)
(15890-25-2)
11.2.1. Acute Dermal LD50 Rabbit: > 16000 mg/kg
11.2.2. Acute Oral LD50 Rat: > 16000 mg/kg
11.3. Distillates (petroleum), hydrotreated light
11.3.1. ORAL (LD50): Acute: >5000 mg/kg [Rat].
11.3.2. DERMAL (LD50): Acute: >2000 mg/kg [Rabbit].
11.3.2.1. Studies on laboratory animals have associated similar materials with eye and respiratory tract
irritation. Repeated exposure to elevated concentrations of hydrocarbon solvents can produce a
variety of transient CNS effects (e.g., dizziness, headache, narcosis, etc). Studies on laboratory
animals have shown similar materials to cause skin irritation after repeated or prolonged contact.
Repeated direct application of similar materials to the skin can produce defatting dermatitis and
kidney damage in laboratory animals. The most common effects observed in repeated dose animal
studies with mineral spirits are kidney changes that are consistent with an alpha 2u‐globulin‐
mediated process that is not regarded as relevant to humans. Certain studies have reported
effects in
the liver as well as hematological or urine chemistry changes. In general, these effects have not to
been shown to be dose‐related.
11.4. Highly-refined petroleum lubricant oils: